| |||||||||||||||||||||||||||||||||||||||||||||
Schedule: 8:30 AM - 8:45 AM Introduction by Chair
Athena F. Zuppa, M.D., MSCE, FCP
The Children’s
8:45 AM – 9:15 AM Pharmacometric Applications to Immunosuppressive
Therapy in Transplant Patients
Alexander A. Vinks, Pharm.D., Ph.D., FCP
Cincinnati Children’s
9:15 AM – 9:45 AM Pharmacotherapy for Critically Ill Preterm Neonates
John N. van den Anker, M.D., Ph.D., FCP, FAAP
Children’s
An Investigator Initiated Perspective Felice Su, M.D. The Children`s
10:15 AM – 10:30 AM Break 10:30 AM – 11:00 AM The ontogeny of inotropic and vasodilator responses Brian D. Hanna, M.D., Ph.D. The Children’s
11:00 AM – 11:30 AM Predicting Pharmacokinetics and Drug-Drug
Interactions in Critically Ill Children
Trevor N. Johnson, Ph.D.
Children’s Hospital
11:30 AM – 12:00 PM Leveraging Opportunities: The Importance of Pediatric Study Design Peter C. Adamson, M.D. The Children’s
Athena F. Zuppa, M.D., MSCE, FCP, Assistant Professor of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA Alexander A. Vinks, Pharm.D., Ph.D., FCP, Professor of Pediatrics and Pharm; Dir. Div. of Clin. Pharm., University of Cincinnati College of Medicine & Pharmacy and Children’s Hospital Medical Center, Cincinnati, OH John N. van den Anker, M.D., Ph.D., FCP, Vice Chair of Pediatrics for Experimental Therapeutics, Children’s National Medical Center, Washington, DC Felice Su, M.D., Assist Professor - Critical Care Medicine/Div. of Clin. Pharm., The Children's Hospital of Philadelphia, Philadelphia, PA Brian D. Hanna, M.D., Ph.D., The Children’s Hospital of Philadelphia, Philadelphia, PA Trevor N. Johnson, Ph.D., Senior Scientist & Senior Pharmacist, Simcyp Limited & Sheffield Children's Hospital, Sheffield, United Kingdom Peter C. Adamson, M.D., The Children’s Hospital of Philadelphia, Philadelphia, PA
| |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||
